Hence, our results also pointed out to DDR machinery activation on GBM cells treated with A5 or C1, as evidenced by the increase of p21 levels, which suggests activation of p53 signaling followed by repression of CCNB1 expression. Here, CDKN1A is linked to glioblastoma.